Antidotes are medicines, chelating drugs, or pharmaceutical ingredients that neutralize the effect of poison or another drug. Paracetamol poisoning is the major concern all over the world as it is the most common drug taken in intentional overdose. Opioid poisoning, cyanide poisoning, benzodiazepine poisoning and other toxins can be neutralized using antidotes. Different types of antidotes are available to neutralize the effect of one particular drug and to reduce the toxicity of many drugs. There are antidotes that are 100% effective, while some can cause fatalities. Examples of antidotes are pralidoxime for poisoning by anti-cholinesterase nerve agents, naloxone for opioid overdose, methylene blue for drug-induced methemoglobinemia, flumazenil for benzodiazepine overdose, dimercaprol for arsenic, gold, or inorganic mercury poisoning, digoxin immune fab for digoxin toxicity, atropine for organophosphates and carbamates, activated charcoal for most poisons, and acetylcysteine for acetaminophen poisoning.
According to the World Health Organization (WHO), over 5 million people across the world suffer from snake bites each year, and nearly 100,000 of these develop severe sequela. Mortality rate in developing countries in Asia Pacific such as India was approximately 30,000, whereas in developed countries in North America such as the U.S. it was 50,000 cases of bites, of which 7,000 were by venomous snakes.
Increase in awareness and studies regarding the identification of toxins of venomous bites by companies and governments to increase the knowledge of antidotes and drugs is projected to drive the global antidotes market during the forecast period. Rise in prevalence of the medical conditions associated with antidotes such as trichotillomania, toxoplasmosis prophylaxis, smoking cessation, reversal of sedation, reversal of opioid sedation, pneumocystis pneumonia prophylaxis, and opioid overdose drives demand for antidotes. However, rise in prices of anti-venoms is anticipated to restrain the global antidotes market during the forecast period.
The global antidotes market can be segmented based on antidote type, dosage form, mode of action, and region. In terms of antidote type, the market can be categorized into chemical antidotes, physical antidotes, and pharmacological antidotes. Based on dosage form, the global antidotes market can be bifurcated into oral and injectable. Oral dosage can be divided into capsules or tablets, and syrup. Based on mode of action, the market can be segmented into poison, drug, and toxin.
Geographically, the global antidotes market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016, due to increase in research and development on antidotes in the region. Europe held the second largest market share in 2016, due to technological advancements in antidotes. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period owing to increase in prevalence of medical conditions associated with antidotes such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning. The market in Latin America and Middle East & Africa is anticipated to be driven by rise in government initiatives regarding antidotes.
Key players in the global antidotes market include ADAPT Pharma, Inc., Baxter International, Inc., Cumberland Pharmaceuticals, Inc., Meridian Medical Technologies, Inc., Graceway Pharmaceuticals, LLC, Luitpold Pharmaceuticals, Inc., Novartis AG, Protherics, Inc., ApoPharma USA, Inc., Apotex, Inc., and Spectrum Pharmaceuticals, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.